Status:

COMPLETED

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Lead Sponsor:

The HIV Netherlands Australia Thailand Research Collaboration

Conditions:

HIV Infections

Eligibility:

FEMALE

18-40 years

Phase:

PHASE2

Brief Summary

To determine the pharmacokinetic profile of generic lopinavir/ritonavir tablets To investigate the possible influence of pregnancy and duration of pregnancy To determine the antiviral activity and saf...

Detailed Description

HAART in pregnant HIV-infected serves two goals, preventing mother to child transmission and providing adequate treatment for the mother. Levels of HIV RNA at delivery and the use of antiretrovirals (...

Eligibility Criteria

Inclusion

  • Documented positive test for HIV-1 infection
  • Subject is at least 18 and not older than 40 years of age at the day of the first dosing of study medication
  • Subject is able and willing to sign the Informed Consent Form prior to screening evaluations.
  • Pregnant for a maximum of 30 weeks at the day of first dosing of study medication

Exclusion

  • History of sensitivity/idiosyncrasy to the drug or chemically related compounds or excipients, which may be employed in the trial.
  • Relevant history or current condition that might interfere with drug absorption, distribution, metabolism or excretion.
  • Inability to understand the nature and extent of the trial and the procedures required.
  • Abnormal serum transaminases or creatinine, determined as levels being \> 3 times upper limit of normal.
  • Concomitant use of medications that interfere with Generic lopinavir/ritonavir pharmacokinetics
  • Active hepatobiliary or hepatic disease (N.B. chronic hepatitis B/C co-infection is allowed)
  • Documented previous virological failure of a lopinavir/ritonavir containing regimen or documented resistance to lopinavir/ritonavir prior to dosing

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00621166

Start Date

June 1 2008

End Date

December 1 2009

Last Update

July 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Obsterics and Gynecology, Faculty of Medicine, Chulalongkorn University

Bangkok, Thailand, 10330